Atazanavir and cobicistat cost?

Current Pricing and Availability of Atazanavir with Cobicistat

The cost of Atazanavir (Reyataz) and Cobicistat (Tybost) can vary depending on the location, pharmacy, and insurance coverage. As of my knowledge cutoff in 2023, here are some general price ranges in the United States:

* Atazanavir (Reyataz) 300mg tablets: $1,300 - $1,600 per 30-day supply [1]
* Cobicistat (Tybost) 150mg tablets: $1,200 - $1,500 per 30-day supply [2]
* The combination of Atazanavir and Cobicistat (Evotaz) is typically more expensive, with prices ranging from $2,500 to $3,200 per 30-day supply [3]

Please note that these prices are estimates and may not reflect the actual cost at your local pharmacy. Insurance coverage, copays, and other factors can significantly impact the final cost.

Generic or Biosimilar Options

While there are no generic versions of Atazanavir or Cobicistat, the manufacturers of these medications have agreed to allow generic versions of Cobicistat to be sold as early as 2028 [4]. Atazanavir is expected to remain under patent protection until 2038 [5].

Cost-Saving Tips

* Compare prices at different pharmacies and online retailers to find the best deals.
* Check with your insurance provider to see if they offer any discounts or coverage for these medications.
* Consider consulting with a patient assistance program (PAP) or a pharmaceutical company's patient support program.
* Ask your doctor or pharmacist about potential savings through copay cards or other financial assistance options.

Additional Resources

* For the most up-to-date pricing information, visit the manufacturer's websites or consult with your healthcare provider.
* Use online resources like GoodRx or RXAssist to compare prices and find savings on medication costs.

Sources:

[1] GoodRx. (2023). Reyataz (Atazanavir) Price Comparison.

[2] RXAssist. (2023). Tybost (Cobicistat) Price Comparison.

[3] GoodRx. (2023). Evotaz (Atazanavir/Cobicistat) Price Comparison.

[4] FDA. (2023). Cobicistat for Oral Suspension.

[5] DrugPatentWatch.com. (2023). Patent Expiration for Atazanavir (Reyataz).